Angiotensin converting enzyme-2 as therapeutic target in COVID-19.

导出 OA

翻译打印收藏纠错

作者： Neda,Roshanravan ^[1] ; Samad,Ghaffari ^[2] ; Mehdi,Hedayati ^[3]

作者单位： Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. ^[1] Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: ghafaris@gmail.com. ^[2] Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: hedayati47@gmail.com. ^[3]

关键词 ACE2 COVID-19 Codeine Morphine SARS-CoV-2 rhACE2

主题词血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);冠状病毒感染(Coronavirus Infections);基因表达调控(Gene Expression Regulation);宿主与病原体相互作用(Host-Pathogen Interactions);人类(Humans);分子靶向治疗(Molecular Targeted Therapy);疾病大流行(Pandemics);肽基二肽酶A(Peptidyl-Dipeptidase A);肺炎, 病毒性(Pneumonia, Viral);受体, 病毒(Receptors, Virus);信号传导(Signal Transduction)

DOI 10.1016/j.dsx.2020.05.022

PMID 32428864

发布时间 2021-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Diabetes & metabolic syndrome

637-639页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Angiotensin converting enzyme-2 as therapeutic target in COVID-19.

Diabetes & metabolic syndrome

相似文献

Diabetes & metabolic syndrome

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Angiotensin converting enzyme-2 as therapeutic target in COVID-19.

Diabetes & metabolic syndrome

相似文献

Diabetes & metabolic syndrome

相关期刊

检索历史清除